Chinese expert consensus on the peri-operative management of hepatectomy for liver cancer (2021 Edition).
10.3760/cma.j.cn112152-20210314-00228
- VernacularTitle:肝癌肝切除围手术期管理中国专家共识(2021年版)
- Collective Name:Cancer Prevention and Treatment Expert Committee, Cross-Straits Medicine Exchange Association
- Publication Type:Journal Article
- Keywords:
Consensus;
Hepatectomy;
Liver neoplasms;
Peri-operative period
- MeSH:
China;
Consensus;
Hepatectomy;
Humans;
Liver Neoplasms/surgery*
- From:
Chinese Journal of Oncology
2021;43(4):414-430
- CountryChina
- Language:Chinese
-
Abstract:
Hepatectomy is a major radical treatment for liver cancer. Although the hepatectomy is of great difficulty for the complicated anatomical structure and rich blood supply of liver, the operative mortality is less than 5% in most treatment centers currently along with the upgrading surgical instruments and developing surgical technology. Nevertheless, it is urgent clinical topic to furtherly reduce the incidence of complication in the wake of hepatectomy, which reaches up to 15%~50%. To standardize the peri-operative management of hepatectomy, on the basis of the standardization for diagnosis and treatment of primary hepatic carcinoma (2019), the Cancer Prevention and Treatment Expert Committee revise and update to produce the expert consensus on the peri-operative management of hepatectomy for liver cancer (2021) according to the opinions of experts in different areas. This consensus takes account of the Chinese characteristics of diagnosis and treatment of liver cancer and follows the concept of enhanced recovery after surgery (ERAS), which will provide reference for the peri-operative management.
